Cencora Inc

Latest Results (07.08.2024):

Revenue Growth

Cencora Inc. reported a significant revenue increase for the first quarter of fiscal 2024, ending December 31, 2023. The company's revenue reached $72.3 billion, marking a 15.0% year-over-year growth. This increase was driven by a 15.9% rise in U.S. Healthcare Solutions revenue and a 6.9% increase in International Healthcare Solutions revenue.

EPS Performance

For the first quarter of fiscal 2024, Cencora Inc. achieved a GAAP diluted earnings per share (EPS) of $2.98, up from $2.33 in the same quarter of the previous year. The adjusted diluted EPS, which excludes certain items, rose by 21.0% to $3.28, compared to $2.71 in the prior year's first quarter.

Operating Income

Cencora Inc.'s operating income for the first quarter of fiscal 2024 was $822.9 million, representing a 30.0% increase from the same period in the previous fiscal year. This growth was primarily due to an increase in gross profit, partially offset by higher operating expenses. Operating income as a percentage of revenue improved to 1.14%.

Adjusted Operating Income

In the first quarter of fiscal 2024, Cencora Inc.'s adjusted operating income was $885.7 million, a 20.7% increase compared to the same period in the prior fiscal year. This growth was driven by a 22.0% increase in U.S. Healthcare Solutions and a 16.3% increase in International Healthcare Solutions. Adjusted operating income as a percentage of revenue was 1.23%.

Updated EPS Guidance

Cencora Inc. has raised its adjusted diluted EPS guidance for fiscal 2024. The new guidance range is $13.25 to $13.50, up from the previous range of $12.70 to $13.00. This update reflects the company's strong performance and positive outlook for the remainder of the fiscal year.